Simultaneous presentation of kappa-restricted chronic lymphocytic leukemia and lambda light chain AL amyloidosis

References

• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–15
   PubMed Web of Science ®Google Scholar
• Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int 1992;42:127–35
   PubMed Web of Science ®Google Scholar
• Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol 2011;29:1924–33
   PubMed Web of Science ®Google Scholar
• Sanchorawala V, Blanchard E, Seldin DC, O’Hara C, Skinner M, Wright DG. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol 2006;81:692–5
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, Plevak MF, Melton III LJ. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. Blood 2003;102:3759–64
   PubMed Web of Science ®Google Scholar
• Gertz MA, Kyle RA, Noel P. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and waldenstrom’s macroglobulinemia. J Clin Oncol 1993;11:914–20
   PubMed Web of Science ®Google Scholar
• Cohen AD, Zhou P, Xiao Q, Fleisher M, Kalakonda N, Akhurst T, Chitale DA, et al. Systemic AL amyloidosis due to non-Hodgkin’s lymphoma: an unusual clinicopathologic association. Br J Haematol 2004;124:309–14
   PubMed Web of Science ®Google Scholar
• Ikee R, Kobayashi S, Hemmi N, Suzuki S, Miura S. Amyloidosis associated with chronic lymphocytic leukemia. Amyloid 2005;12:131–4
   PubMed Web of Science ®Google Scholar
• Simmonds PD, Cottrell BJ, Mead GM, Wright DH, Whitehouse JM. Lymphadenopathy due to amyloid deposition in non-Hodgkin’s lymphoma. Ann Oncol 1997;8:267–70
   PubMedGoogle Scholar
• Dou X, Hu H, Ju Y, Liu Y, Kang K, Zhou S, Chen W. Concurrent nephrotic syndrome and acute renal failure caused by chronic lymphocytic leukemia (CLL): a case report and literature review. Diagn Pathol 2011;13:6–99
   Google Scholar
• Keating MJ, O’Brien S, Albitar M, Lerner S, Plunkett W, Giles F, Andreeff M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol 2005;23:4079–88
   PubMed Web of Science ®Google Scholar
• Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM, Katzmann JA, et al. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Transl Res 2007;149:231–5
   PubMed Web of Science ®Google Scholar
• Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, Marti GE, et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 2009;114:4928–32
   PubMed Web of Science ®Google Scholar
• Carney D, Mummadi S, Lerner S, Keating M, Paraproteins in CLL are frequently the product of another clone. ASH abstract 2004; ISSN 0006–4971
   Google Scholar
• Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, et al. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 2013;88:375–8
   PubMed Web of Science ®Google Scholar
• Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, Hillmen P, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the international workshop on chronic lymphocytic leukemia updating the national cancer institute-working group 1996 guidelines. Blood 2008;111:5446–5
   PubMed Web of Science ®Google Scholar
• Sanchorawala V, Skinner M, Quillen K, Finn KT, Doros G, Seldin DC. Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation. Blood 2007;110:3561–3
   PubMed Web of Science ®Google Scholar
• Specter R, Sanchorawala V, Seldin DC, Shelton A, Fennessey S, Finn KT, Zeldis JB, et al. Kidney dysfunction during lenalidomide treatment for AL amyloidosis. Nephrol Dial Transplant 2011;26:881–6
   PubMed Web of Science ®Google Scholar